Related references
Note: Only part of the references are listed.Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines
Jonas Parczyk et al.
BMC CANCER (2021)
Pharmacokinetic Characterization of LW6, a Novel Hypoxia-Inducible Factor-1α (HIF-1α) Inhibitor in Mice
Ji-Yoon Lee et al.
MOLECULES (2021)
The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy
Yue Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia
Abhishek Sahu et al.
BIOMATERIALS (2020)
Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils
Karim Mahiddine et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
HIF Inhibitors: Status of Current Clinical Development
Jaleh Fallah et al.
CURRENT ONCOLOGY REPORTS (2019)
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Najah Albadari et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
Reem Saleh et al.
CANCERS (2019)
Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
Julian Pineiro Fernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Cedric Magaway et al.
CELLS (2019)
Multiplexed Single-Cell Measurements of FDG Uptake and Lactate Release Using Droplet Microfluidics
Debanti Sengupta et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Large Intergenic Non-coding RNA-RoR Inhibits Aerobic Glycolysis of Glioblastoma Cells via Akt Pathway
Yong Li et al.
JOURNAL OF CANCER (2018)
Hypoxia-Driven immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational immunotherapy
Yiliang Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
Monica Parodi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: systems molecular imaging of glucose metabolism
Baozhong Shen et al.
ONCOTARGET (2017)
Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
Eva M. Palsson-McDermott et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
Molecular mechanisms of hypoxia in cancer
Amarnath Challapalli et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy
Natalia Baran et al.
CLINICAL CANCER RESEARCH (2017)
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities
Sonia Y. Velasquez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma
Yong Qin et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system
Sung Hoon Cho et al.
NATURE (2016)
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
John D. Martin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
Muhammad Zaeem Noman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
18F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer
Ya-Li Cui et al.
FUTURE ONCOLOGY (2015)
From mice to humans: developments in cancer immunoediting
Michele W. L. Teng et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The Reverse Warburg Effect and 18F-FDG Uptake in Non-Small Cell Lung Cancer A549 in Mice: A Pilot Study
Guojian Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Using tumour phylogenetics to identify the roots of metastasis in humans
Kamila Naxerova et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection
Akil Hammami et al.
PLOS PATHOGENS (2015)
Imaging tumour hypoxia with positron emission tomography
I. N. Fleming et al.
BRITISH JOURNAL OF CANCER (2015)
Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT
Chowdhury Nusrat Fatema et al.
BMC CANCER (2014)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
HIF Transcription Factors, Inflammation, and Immunity
Asis Palazon et al.
IMMUNITY (2014)
Short-Term Hypoxia Enhances the Migratory Capability of Dendritic Cell Through HIF-1 and PI3K/Akt Pathway
Irene Filippi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
A. Casazza et al.
ONCOGENE (2014)
Hypermutable DNA chronicles the evolution of human colon cancer
Kamila Naxerova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
Kenta Masui et al.
CELL METABOLISM (2013)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression
Daniele Pierobon et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Tumor Microenvironment-Dependent 18F-FDG, 18F-Fluorothymidine, and 18F-Misonidazole Uptake: A Pilot Study in Mouse Models of Human Non-Small Cell Lung Cancer
Tao Huang et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Hypoxia imaging with PET: which tracers and why?
Kazumi Chia et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo
Maria Carla Bosco et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography
Xiao-Feng Li et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Johanna Chiche et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
High 18F-FDG Uptake in Microscopic Peritoneal Tumors Requires Physiologic Hypoxia
Xiao-Feng Li et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
PET-CT for response assessment and treatment adaptation in head and neck cancer
Johan Bussink et al.
LANCET ONCOLOGY (2010)
Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
Alfredo Toschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy
Xiao-Feng Li et al.
CANCER RESEARCH (2007)
Targeting the molecular effects of a hypoxic tumor microenvironment
L. Isabel Cardenas-Navia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype
GN Naumov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Dependence of FDG uptake on tumor microenvironment
A Pugachev et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
The role of hypoxia-induced factors in tumor progression
P Vaupel
ONCOLOGIST (2004)
Prognostic significance of tumor oxygenation in humans
SM Evans et al.
CANCER LETTERS (2003)
Mechanisms and future directions for angiogenesis-based cancer therapies
FA Scappaticci
JOURNAL OF CLINICAL ONCOLOGY (2002)
Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy
T Udagawa et al.
FASEB JOURNAL (2002)
Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo
JA Aguirre-Ghiso et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
